Showing results (931-940 of 2,148) with videos related to
Sort By:
Pageof 215
Future Microbiology|February 18, 2015
Phages targeting infected tissues: novel approach to phage therapyAndrzej Górski, Krystyna Dąbrowska, Katarzyna Hodyra-Stefaniak, et al.Future Microbiology|February 18, 2015
Differential diagnostic assays for discriminating mycobacteria, especially for nontuberculous mycobacteria: what does the future hold?Yoshihiko Hoshino, Koichi SuzukiFuture Microbiology|February 18, 2015
The future for early-stage tuberculosis drug discoveryEdison S Zuniga, Julie Early, Tanya ParishFuture Microbiology|March 28, 2015
Endolysins: redefining antibacterial therapyBjorn Lars Herpers, Natasha LeesonFuture Microbiology|March 28, 2015
RfiA, a novel PAP2 domain-containing polytopic membrane protein that confers resistance to the FtsZ inhibitor PC190723Ximing Chen, Binglin Zhang, Jianxi Xiao, et al.Future Microbiology|March 28, 2015
Emerging issues in antimicrobial resistance of bacteria from food-producing animalsGeovana Brenner Michael, Christin Freitag, Sarah Wendlandt, et al.Future Microbiology|July 15, 2020
Long-term morbidity and mortality in Whipple's disease: a single-center experience over 20 yearsAnnalisa Schiepatti, Maria Luisa Nicolardi, Piero Marone, et al.Future Microbiology|January 24, 2014
The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumoniaSteven L BarriereFuture Microbiology|October 4, 2012
Bacteriophage endolysins as novel antimicrobialsMathias Schmelcher, David M Donovan, Martin J LoessnerFuture Microbiology|September 1, 2021
Transcriptomics and methylomics study on the effect of iodine-containing drug FS-1 on Escherichia coli ATCC BAA-196Ilya S Korotetskiy, Ardak B Jumagaziyeva, Sergey V Shilov, et al.Pageof 215